1Kinsella JP,Abman SH. Recent developments in the pathophysiology and treatment of persistent pulmonary hypertension of the newborn. J Pediatr, 1995,126 : 853-864.
2Clark RH, Kueser TJ, Walker MW, et al. Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. Clinical Inhaled Nitric Oxide Research Group. N Engl J Med, 2000,342:469-474.
3Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. The Neonatal Inhaled Nitric Oxide Study Group. N Engl J Med,1997 ,336 :597-604.
2Kinsella S, Neish SR, Shaffer E, et al. Low-dose inhslaticmsl nitricoxide in persistent pulmonary hypertension of the newborn.Lancet, 1992,340:819.
3Robert JD, Polaner DM, Lang P, et al. Inhaled nitric oxide in per-sistertt pulmonary hypertension of the newborn. Lancet, 1992,340:818.
4Roberts JD, Chen TY,Kawai N,et al. Inhaled nitric oxide reversespulrrmnary vasoconstriction in the hypoxic and acidotic new bornlamb. Circ Res, 1993,72:246.
5Rossiant R,Falk KJ,Lopez,et al. Inhaled nitric oxide for the adultrespiratory distress syndrome. N Engl J Med, 1993,328:399.
6Winberg P,Lundell BP,Gustafsson LE,et al. Effect of inhaled ni-tric oxide on raised pulmonary vascular resistance in children withcongenital heart disease. Br Heart J, 1994,1(3) :282.
7Ronald WD,Joanna ML, Keith SW, et al. Acute response to inhalednitric oxide in newborn with respiratory failure and pulmonary hy-pertension. Pediatric, 1996,98 : 698.
8Radomski A, Sawicki G,Olson DM, et al. The role of nitric oxideand metalloproteinases in the pathogenesis of hyperoxia-inducedlung injury in newborn rats. Br J Pharmacol, 1998,125( 7 ) : 1455.
9Carat C,Jayr C, Eddahibi S, et al. Effects of inhaled nitric oxide orinhibition of endogenous nitric oxide formation on hyperoxic lunginjury. Am J Respir Crit Care Med, 1997,155(6) : 1957.
10Zapol WM, Rimar S,Gillis N, et al. Nitric oxide and the lung. Am J Respir Crit Care Med, 1994,149:1375.
